1-2g IV q8-12h
Suspected or documented Pseudomonas aeruginosa infection and in the management of gram-negative meningitis.
Broad spectrum antimicrobial with gram positive and gram negative coverage including Pseudomonas.
Used especially nosocomial infections involving resistant organisms
Other GI effects
Higher dosing may be required for cystic fibrosis and/or febrile neutropenia
Antimicrobial class: 4th generation Cephalosporin
Pregnancy category: B
Average serum half life: 2 hours
Biliary penetration: Moderate
CSF penetration: Therapeutic
Urine penetration: Therapeutic
Lung penetration: Therapeutic